Table 1 Clinicopathological variables between the two groups

Gender, M/F

76/12

66/7

0.428

31/6

32/5

0.744

Age (year), < 50/≥ 50

39/49

43/30

0.065

19/18

20/17

0.816

AFP level (ng/ml), < 400/≥ 400

58/30

48/25

0.751

22/15

22/15

1.000

BCLC stage, 0,A/B,C

49/39

55/18

0.009

28/9

24/13

0.309

Tumor size (cm), < 5/≥ 5

40/48

52/21

0.001

26/11

25/12

0.802

Tumor number, < 3/≥ 3

84/4

70/3

0.893

35/2

36/1

0.556

Capsule integrity, yes/no

54/34

62/11

0.001

27/10

26/11

0.797

Satellite nodule, yes/no

7/81

7/66

0.714

5/32

5/32

1.000

Vascular invasion, yes/no

36/52

17/56

0.018

8/29

12/25

0.295

MVI, yes/no

3/85

5/68

0.317

1/36

2/35

0.556

Necrosis, yes/no

18/70

9/64

0.169

4/33

4/33

1.000

Liver cirrhosis, yes/no

41/47

52/21

0.002

19/18

22/15

0.483

PHT, yes/no

32/56

31/42

0.430

13/24

15/22

0.632

Anatomical hepatectomy, yes/no

32/56

39/34

0.030

14/23

15/22

0.812

Blood loss (ml), < 500/≥ 500

75/13

62/11

0.958

31/6

33/4

0.496

Operative time (min), < 120/≥ 120

3/85

7/66

0.106

1/36

0/37

0.314

ALT (U/L), < 40/≥ 40

51/37

44/29

0.766

22/15

23/14

0.812

ALB (g/L), ≤36/> 36

16/72

10/63

0.442

7/30

6/31

0.760

PT (s), < 13/≥ 13

63/25

52/21

0.960

27/10

27/10

1.000

HBV reactivation, yes/no

20/68

2/71

0.001

3/34

2/35

0.643